Press releaseGlobe Newswire
First Tracks Biotherapeutics
TRAX · NASDAQ
$41.25+$4.97 (+13.70%)TodayMarket closed ·
Prev close $36.28
Latest news
- NewsAvi Kapoor
Dow Gains Over 200 Points; Chipotle Shares Move Lower
- NewsAvi Kapoor
First Tracks Biotherapeutics, C3.ai, CCC Intelligent Solutions And Other Big Stocks Moving Higher On Monday
- NewsRishabh Mishra
Stock Market Today: S&P 500, Dow Futures Gain, Nasdaq 100 Falls as Iran Flags ‘Inadequate’ US Response to Peace Terms — SMP, QMCO, SVRN in Focus (UPDATED)
- NewsVandana Singh
Why Is First Tracks Biotherapeutics Stock Soaring Monday?
- Press releaseGlobe Newswire
First Tracks Biotherapeutics Announces Positive Top-Line Results for ANB033 in Gluten-Challenge Study in Celiac Disease
- NewsAvi Kapoor
Why J-Star Holding Shares Are Trading Higher By Around 128%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
First Tracks Biotherapeutics to Announce Top-Line Data from Cohort 1 of Phase 1b Trial of ANB033, a CD122 antagonist, in Celiac Disease on Oct. 12, 2026
- NewsAvi Kapoor
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
- Press releaseGlobe Newswire
First Tracks Biotherapeutics Announces Participation in September Investor Conferences
- NewsAvi Kapoor
First Tracks Biotherapeutics Analysts Increase Their Forecasts After Q2 Results
- Press releaseGlobe Newswire
First Tracks Biotherapeutics Announces Second Quarter 2026 Financial Results and Provides Business Update
- NewsAvi Kapoor
Baker Hughes Posts Upbeat Q2 Earnings, Joins Forte Biosciences, Eikon Therapeutics And Other Big Stocks Moving Higher On Monday
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAvi Kapoor
Hasbro, Utz Brands, Park Aerospace And Other Big Stocks Moving Higher On Tuesday
- Press releaseGlobe Newswire
First Tracks Biotherapeutics Announces Participation in Upcoming Investor Conferences
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- Press releaseGlobe Newswire
First Tracks Biotherapeutics Announces First Quarter 2026 Financial Results and Provides Business Update
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Press releaseGlobe Newswire
First Tracks Biotherapeutics Debuts on Nasdaq to Advance Therapies for Autoimmune Diseases
- Press releaseGlobe Newswire
Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update
- Press releaseGlobe Newswire
Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.